메뉴 건너뛰기




Volumn 118, Issue 16, 2012, Pages 3893-3898

Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy

Author keywords

breast cancer; breast conservation surgery; local recurrence; molecular phenotype; molecular subtype; radioresistance; radiotherapy; triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

EID: 84864710363     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27376     Document Type: Article
Times cited : (23)

References (30)
  • 1
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000; 406: 747-752.
    • (2000) Nature. , vol.406 , pp. 747-752
    • Perou, C.M.1    Sørlie, T.2    Eisen, M.B.3
  • 2
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98: 10869-10874.
    • (2001) Proc Natl Acad Sci U S A. , vol.98 , pp. 10869-10874
    • Sørlie, T.1    Perou, C.M.2    Tibshirani, R.3
  • 3
    • 0037478605 scopus 로고    scopus 로고
    • Repeated observation of breast tumor subtypes in independent gene expression data sets
    • Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003; 100: 8418-8423.
    • (2003) Proc Natl Acad Sci U S A. , vol.100 , pp. 8418-8423
    • Sorlie, T.1    Tibshirani, R.2    Parker, J.3
  • 4
    • 0042838307 scopus 로고    scopus 로고
    • Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    • Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A. 2003; 100: 10393-10398.
    • (2003) Proc Natl Acad Sci U S A. , vol.100 , pp. 10393-10398
    • Sotiriou, C.1    Neo, S.Y.2    McShane, L.M.3
  • 5
    • 33744960226 scopus 로고    scopus 로고
    • Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    • Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006; 295: 2492-2502.
    • (2006) JAMA. , vol.295 , pp. 2492-2502
    • Carey, L.A.1    Perou, C.M.2    Livasy, C.A.3
  • 6
    • 4143150688 scopus 로고    scopus 로고
    • Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
    • Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004; 10: 5367-5374.
    • (2004) Clin Cancer Res. , vol.10 , pp. 5367-5374
    • Nielsen, T.O.1    Hsu, F.D.2    Jensen, K.3
  • 7
    • 44249114098 scopus 로고    scopus 로고
    • Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
    • Nguyen PL, Taghian AG, Katz MK, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008; 26: 2373-2378.
    • (2008) J Clin Oncol. , vol.26 , pp. 2373-2378
    • Nguyen, P.L.1    Taghian, A.G.2    Katz, M.K.3
  • 8
    • 70350441646 scopus 로고    scopus 로고
    • Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel
    • Millar EK, Graham PH, O'Toole SA, et al. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol. 2009; 27: 4701-4708.
    • (2009) J Clin Oncol. , vol.27 , pp. 4701-4708
    • Millar, E.K.1    Graham, P.H.2    O'Toole, S.A.3
  • 9
    • 61449142636 scopus 로고    scopus 로고
    • Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation
    • Freedman GM, Anderson PR, Li T, Nicolaou N,. Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer. 2009; 115: 946-951.
    • (2009) Cancer. , vol.115 , pp. 946-951
    • Freedman, G.M.1    Anderson, P.R.2    Li, T.3    Nicolaou, N.4
  • 11
    • 78149256247 scopus 로고    scopus 로고
    • Triple-negative breast cancers: Unique clinical presentation and outcomes
    • Billar JA, Dueck AC, Stucky CC, et al. Triple-negative breast cancers: unique clinical presentation and outcomes. Ann Surg Oncol. 2010; 17 (suppl 3): 384-390.
    • (2010) Ann Surg Oncol. , vol.17 , Issue.SUPPL. 3 , pp. 384-390
    • Billar, J.A.1    Dueck, A.C.2    Stucky, C.C.3
  • 12
    • 41149125468 scopus 로고    scopus 로고
    • Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group
    • Danish Breast Cancer Cooperative Group.
    • Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J,; Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008; 26: 1419-1426.
    • (2008) J Clin Oncol. , vol.26 , pp. 1419-1426
    • Kyndi, M.1    Sørensen, F.B.2    Knudsen, H.3    Overgaard, M.4    Nielsen, H.M.5    Overgaard, J.6
  • 13
    • 77957191754 scopus 로고    scopus 로고
    • Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status
    • Wilder RB, Curcio LD, Khanijou RK, et al. Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Int J Radiat Oncol Biol Phys. 2010; 78: 799-803.
    • (2010) Int J Radiat Oncol Biol Phys. , vol.78 , pp. 799-803
    • Wilder, R.B.1    Curcio, L.D.2    Khanijou, R.K.3
  • 14
    • 79957723055 scopus 로고    scopus 로고
    • Triple-negative breast cancer is associated with higher risk of local recurrence after 3D-conformal external beam accelerated partial breast irradiation (3D-CRT)
    • abstract 112
    • Pashtan IM, Ancukiewicz M, Wo JY, et al. Triple-negative breast cancer is associated with higher risk of local recurrence after 3D-conformal external beam accelerated partial breast irradiation (3D-CRT). Int J Radiat Oncol Biol Phys. 2010; 78 (3 suppl): S53 (abstract 112).
    • (2010) Int J Radiat Oncol Biol Phys. , vol.78 , Issue.3 SUPPL.
    • Pashtan, I.M.1    Ancukiewicz, M.2    Wo, J.Y.3
  • 15
    • 34547661993 scopus 로고    scopus 로고
    • Triple-negative breast cancer: Clinical features and patterns of recurrence
    • Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007; 13: 4429-4434.
    • (2007) Clin Cancer Res. , vol.13 , pp. 4429-4434
    • Dent, R.1    Trudeau, M.2    Pritchard, K.I.3
  • 16
    • 0030754134 scopus 로고    scopus 로고
    • The value of lumpectomy margin assessment as a predictor of residual tumor burden
    • Wazer DE, Schmidt-Ullrich RK, Schmid CH, et al. The value of lumpectomy margin assessment as a predictor of residual tumor burden. Int J Radiat Oncol Biol Phys. 1997; 38: 291-299.
    • (1997) Int J Radiat Oncol Biol Phys. , vol.38 , pp. 291-299
    • Wazer, D.E.1    Schmidt-Ullrich, R.K.2    Schmid, C.H.3
  • 17
    • 0032724667 scopus 로고    scopus 로고
    • The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor
    • Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al. The influence of age and extensive intraductal component histology upon breast lumpectomy margin assessment as a predictor of residual tumor. Int J Radiat Oncol Biol Phys. 1999; 45: 885-891.
    • (1999) Int J Radiat Oncol Biol Phys. , vol.45 , pp. 885-891
    • Wazer, D.E.1    Schmidt-Ullrich, R.K.2    Ruthazer, R.3
  • 19
    • 73949136029 scopus 로고    scopus 로고
    • The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: A retrospective of the last decade
    • Weigelt B, Baehner FL, Reis-Filho JS,. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol. 2010; 220: 263-380.
    • (2010) J Pathol. , vol.220 , pp. 263-380
    • Weigelt, B.1    Baehner, F.L.2    Reis-Filho, J.S.3
  • 20
    • 43949095489 scopus 로고    scopus 로고
    • How basal are triple-negative breast cancers?
    • Bertucci F, Finetti P, Cervera N, et al. How basal are triple-negative breast cancers? Int J Cancer. 2008; 123: 236-240.
    • (2008) Int J Cancer. , vol.123 , pp. 236-240
    • Bertucci, F.1    Finetti, P.2    Cervera, N.3
  • 21
    • 34247569300 scopus 로고    scopus 로고
    • Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: A population-based study from the California Cancer Registry
    • Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V,. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California Cancer Registry. Cancer. 2007; 109: 1721-1728.
    • (2007) Cancer. , vol.109 , pp. 1721-1728
    • Bauer, K.R.1    Brown, M.2    Cress, R.D.3    Parise, C.A.4    Caggiano, V.5
  • 23
    • 0141429017 scopus 로고    scopus 로고
    • Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
    • Foulkes WD, Stefansson IM, Chappuis PO, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003; 95: 1482-1485.
    • (2003) J Natl Cancer Inst. , vol.95 , pp. 1482-1485
    • Foulkes, W.D.1    Stefansson, I.M.2    Chappuis, P.O.3
  • 24
    • 22344443194 scopus 로고    scopus 로고
    • Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
    • Breast Cancer Linkage Consortium.
    • Lakhani SR, Reis-Filho JS, Fulford L, et al. Breast Cancer Linkage Consortium. Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res. 2005; 11: 5175-5180.
    • (2005) Clin Cancer Res. , vol.11 , pp. 5175-5180
    • Lakhani, S.R.1    Reis-Filho, J.S.2    Fulford, L.3
  • 25
    • 46949096398 scopus 로고    scopus 로고
    • Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer
    • Crabb SJ, Cheang MC, Leung S, et al. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer. 2008; 8: 249-256.
    • (2008) Clin Breast Cancer. , vol.8 , pp. 249-256
    • Crabb, S.J.1    Cheang, M.C.2    Leung, S.3
  • 26
    • 69049088222 scopus 로고    scopus 로고
    • Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
    • Foulkes WD, Grainge MJ, Rakha EA, Green AR, Ellis IO,. Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status. Breast Cancer Res Treat. 2009; 117: 199-204.
    • (2009) Breast Cancer Res Treat. , vol.117 , pp. 199-204
    • Foulkes, W.D.1    Grainge, M.J.2    Rakha, E.A.3    Green, A.R.4    Ellis, I.O.5
  • 28
    • 41649102048 scopus 로고    scopus 로고
    • Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
    • Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008; 26: 1275-1281.
    • (2008) J Clin Oncol. , vol.26 , pp. 1275-1281
    • Liedtke, C.1    Mazouni, C.2    Hess, K.R.3
  • 29
    • 34548243731 scopus 로고    scopus 로고
    • Impact of higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial
    • Bartelink H, Horiot JC, Poortmans PM, et al. Impact of higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol. 2007; 25: 3259-3265.
    • (2007) J Clin Oncol. , vol.25 , pp. 3259-3265
    • Bartelink, H.1    Horiot, J.C.2    Poortmans, P.M.3
  • 30
    • 74549138808 scopus 로고    scopus 로고
    • Impact of pathological characteristics on local relapse after breast-conserving therapy: A subgroup analysis of the EORTC boost versus no boost trial
    • Jones HA, Antonini N, Hart AA, et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol. 2009; 27: 4939-4947.
    • (2009) J Clin Oncol. , vol.27 , pp. 4939-4947
    • Jones, H.A.1    Antonini, N.2    Hart, A.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.